# ARTEMIS: Study of Patients With Early Stage Pancreatic Cancer Who Have Undergone Genetic Testing

> **NCT05380557** · — · TERMINATED · sponsor: **Invitae Corporation** · enrollment: 2 (actual)

## Conditions studied

- Pancreatic Adenocarcinoma
- Pancreatic Cancer
- Resectable Pancreatic Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Germline genetic testing

## Key facts

- **NCT ID:** NCT05380557
- **Lead sponsor:** Invitae Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2021-08-23
- **Primary completion:** 2022-09-06
- **Final completion:** 2022-09-06
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Low site engagement and accrual
- **Last updated:** 2022-12-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05380557

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05380557, "ARTEMIS: Study of Patients With Early Stage Pancreatic Cancer Who Have Undergone Genetic Testing". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05380557. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*